Your browser doesn't support javascript.
loading
Cytometric analysis of cell suspension generated by cavitron ultrasonic surgical aspirator in pediatric brain tumors.
Vaskova, Martina; Tichy, Michal; Zamecnik, Josef; Liby, Petr; Kuzilkova, Daniela; Vicha, Ales; Hrabeta, Jan; Kalina, Tomas; Stary, Jan; Hrusak, Ondrej.
Afiliación
  • Vaskova M; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic. martina.vaskova@lfmotol.cuni.cz.
  • Tichy M; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. martina.vaskova@lfmotol.cuni.cz.
  • Zamecnik J; Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Liby P; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Kuzilkova D; Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Vicha A; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.
  • Hrabeta J; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Kalina T; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Stary J; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Hrusak O; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.
J Neurooncol ; 143(1): 15-25, 2019 May.
Article en En | MEDLINE | ID: mdl-30827009
ABSTRACT

PURPOSE:

The aim of this study was to test the possibility of using specimens obtained by a cavitron ultrasonic surgical aspirator (CUSA) in flow and mass cytometry investigations of pediatric brain tumors.

METHODS:

CUSA specimens obtained from 19 pediatric patients with brain tumors were investigated. Flow and mass cytometry methods were applied to analyze the composition of material collected using the CUSA. Cell suspensions were prepared from CUSA aspirates. Then sample viability was assessed by conventional flow cytometry and subsequently stained with a panel of 31 metal-labeled antibodies.

RESULTS:

Viability assessment was performed using conventional flow cytometry. Viability of cells in the acquired samples was below 50% in 16 of 19 cases. A mass cytometry investigation and subsequent analysis enabled us to discriminate brain tumor cells from contaminating leukocytes, whose proportions varied across the specimens. The addition of the viability marker cisplatin directly into the mass cytometry panel gave the means to selecting viable cells only for subsequent analyses. The proportion of non-viable cells was higher among tumor cells compared leukocytes.

CONCLUSIONS:

When the analysis of the tumor cell immunophenotype is performed with markers for determining viability, the expression of the investigated markers can be evaluated. Suitable markers can be selected by high-throughput methods, such as mass cytometry, and those that are diagnostically relevant can be investigated using flow cytometry, which is more flexible in terms of time.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas Límite: Humans Idioma: En Revista: J Neurooncol Año: 2019 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas Límite: Humans Idioma: En Revista: J Neurooncol Año: 2019 Tipo del documento: Article País de afiliación: República Checa